Bill > HB1195

This bill makes several significant changes to pharmacy and health insurance regulations in Missouri. It expands the definition of pharmacy practice to include dispensing an emergency supply of insulin without a current prescription under specific conditions, such as when a pharmacist cannot obtain prescription authorization and believes withholding medication would endanger the patient's health. The bill also introduces new requirements for health insurance providers, mandating that insurers limit patient out-of-pocket costs for insulin drugs to $35 for a 30-day supply, diabetes devices to $100, and epinephrine delivery devices to $100. Additionally, the legislation requires the departments of commerce and insurance, health, and social services to produce a public report by November 1, 2025, detailing insulin and medical device pricing practices and potential policy recommendations. The bill further stipulates that pharmacy benefits managers must reimburse pharmacies at least their actual drug acquisition cost plus a minimum dispensing fee of $15 per prescription to cover professional services and operational costs. These provisions aim to improve patient access to essential medical products and provide more transparency in healthcare pricing.

Government Affairs, Health and Social Services

https://house.mo.gov/Bill.aspx?bill=HB1195&year=2025&code=R